Skip to content
NCCPDI_Long
  • About Us
    • Mission & Goals
    • Team
    • Partners
    • FAQs
  • Resources
    • Consulting
    • Pediatric Device Events
    • Media
  • NCC-PDI Competition
  • Projects
  • Contact Us
Menu
  • About Us
    • Mission & Goals
    • Team
    • Partners
    • FAQs
  • Resources
    • Consulting
    • Pediatric Device Events
    • Media
  • NCC-PDI Competition
  • Projects
  • Contact Us
Search
Close

3D bioprinted placenta model could be the key to treating preeclampsia

  • May 19, 2016
Read More...

Preeclampsia, a pregnancy disorder usually occurring in the late stages of pregnancy, is one of the leading causes of both maternal and perinatal morbidity and mortality today. On a global scale, the condition affects three to eight percent of pregnant women, and in 2013 preeclampsia resulted in 29,000 deaths. Unfortunately, and because of the ethical difficulty in testing pregnant women, little is known about the potentially fatal condition, and the only route for treatment is usually a premature delivery.

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
PrevPreviousAddressing Unmet Need, Pediatric Device Innovators Awarded $250,000
NextStudies shine light on mysterious placenta, how it goes awryNext
Innovate4Kids

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) serves as a critical device development resource by providing expert advice, support services, and fund management of pediatric device innovation.

About Us

  • Mission & Goals
  • Team
  • Partners
  • FAQs
  • Privacy Policy

Resources

  • Consulting
  • Pediatric Device Events

Contact Us

NCC-PDI@childrensnational.org

© All rights reserved